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ABSTRACT
The relationship of thyroid and monoamine ox i dase act i vi t y t o

locomotor responses was in•estigated.
Locomotor activi ty was measured by use of actophotometers.

Four

mice were placed in the actophotometer and counts were recorded at
specific time intervals up to two hours.

The administration of thyroid,

M0911, and combined thyroid and M0911 did not alter spontaneous activity

significantly.
Monoamine oxidase activity of brains and livers was measured in
vitro using the Warburg apparatus.
tion was 28 minutes.

The elapsed time for tissue respira-

Thyroid administration did not alter monoamine

oxidase activity significantly in liver but brain activity was decreased.
Therapy with M0911 decreased liver monoamine oxidase activity sharply
and also depressed brain activity.

Combined therapy with thyroid and

M0911 decreased liver monoamine oxidase activity less effectively

than M>911 alone.

Brain m.onoamine oxidase activity was also depressed.

No correlation was found to exist between monoamine oxidase
activity and locomotor responses following thyroid, M0911, and combined
thyroid and M09ll therapy.
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I.

INTROoucnoN

The advent of psychic energizers in 1952 represents a new frontier
in the treatment of primary mental depression.

Therapeutic doses in hu-

mans achieved excellent results by elevating the mood of the patient and

improving psychic energy.

Responses to these drugs were correlated with

the decrease of monoa1Bine oxidase (MAO) activity in the body thereby el-

evating the concentrations of brain and tissue catecholamines.
Diverse effects have been described following the use of thyroid.
Among these is the decrease in MAO activity.

There have been dissenters

to this view but the evidence preponderantly favors the assenting viewpoint.

The precise mechanism which is altered to produce the

en~yme

reduction has not been clatifi&d.
Theoretically. combination therapy of • MAO inhibitor and thyroid
should combat' depression more effectively than either alone.

lf another

metabolic effect of thyroid is considered, such as an elevated basal
metabolic rate, a more potent therapeutic combination should be predicted.
Inexplicably, this is not the result.

Thyroid and MAO therapy produces

retardation and apathy in depressed patients.
This investigation is an attempt to resolve the apparent p radox
by studying the intet-relationships of MAO activity in brain nd U-ver.
This will be approached by administering thyroid, MAO inhibitor and a
combination of thyroid and MAO inhibitor to experimental animals •

.' .

.. ,
4

II.

SURVEY OF THE LITERATURE

At the turn of the century, Eppinger, Falta and Rudinger (cf. Burn

& Marks, 1925) found that in thyroidectomized dogs an injection of adrenaline did not cause glycosuria.

Burn and Marks (1925) studied the glyce-

mic responses associated with adrenaline and insulin and found an inverse
relationship resulting from the activity of adrenalin and insulin.

Adren-

aline promoted glycogenolysis and insulin produced a hypoglycemic state.
These investigators also noted that thyroidectomy produces an increase
in insulin hypoglycemia and a decrease in adrenalin hyperglycemia.

Al-

though Burn and Marks did not attribute this phenomena to MAO activity,
the implication that this enzyme may have been responsible is e•ident
from subsequent knowledge.
Interactions of thyroid and sympathomimetic amine1 were found on
a gross tissue respone level.

Sawyer (1935) explored the effects of

thyroidectomy and thyroxine on the response of the denervated heart to
injected and secreted adrenaline.

Thyroidectomy decreased the response

of the denervated heart of the cat to injected and secreted adrenaline.
Their conclusion suggests that the "sensitization" of heart tissue to
adrenaline is caused by thyroid • . Oehme (1936) reported that the adrenal
cortical hormone po1sesses an antithyrotropic action as it decreased the
elevated basal metabolic rate (BMR) in guinea pigs.

The action of adren-

al cortical secretion was effective whether the hyperthyroid state was
caused by parenteral thyroxine or by dietary feeding and furthermore,
the activity of ascorbic acid paralleled the activity of the horll\One of
the adrenal cortex.

Developing this theory Oehme (1937) eX:perimented

with thyroid, the adrenal cortex hormone, ascorbic acid and amino acids.
Tb.e results indicated that the hormone of the adrenal cortex not only

s

6.

lowers the increased metabolism of guinea pigs after thyroxine but also
prolongs the life span of ani111als poisoned with thyroxine.

Glycine ex-

hibited essentially the same effect in experimental hyperthyroidism as
the adrenal hormone, but in euthyroid guinea pigs it lowered metabolism
after a prolonged period.

Brewster et al. (1956) demonstrated the aug-

mentation of the effects of epinephrine by thyroid.
deprived of

~11

sources of

Hyperthyroid animals

epinephrine returned to the euthyroid state.

These experiments indicate that thyroid sensitizes heart tissue to
adrenaline.

Furthermore, thyroid•s action is inhibited by the hormone

of the adrenal cortex, ascorbic acid, and amino acids.
The hypothesis of a possible thyroid-adrenal interplay was demonstrated by the work of Rokhlina (1957).

He

techniques in the chick embryo, that adrenal

h~s

shown by implantation

cort~x

tissue implanted in

the chorio-allantoic envelope of the 8 day embryo inhibited the develop
ment of the thyroid gland.

0

The inhibition was especially prominent 12

to 14 days after incubation.

Lang (1938) noted that rats rapidly in-

jected subcutaneously with adrenaline, demonstrated a slight increase in
the colloid content of the thyroid gland with concomitant proliferation
of the epithelium.

Hoen (1939) determined hormonal relationships between

the thyroid and adrenal glands.

He found that desoxycorticosterone in-

hibited the metabolic effect of thyroxine but did not prevent the loss
of weight orpro!ong the survival of rats.
als in the hyperthyroid state

~as

The hypertrophy of the adren-

inhibited by the adrenal hormone and

the same type of hypertrophy was observed in hypophysectomized rats.
The inhibition of the thyrotropic stimulating hormone by thyroxine is
accompanied by a release of corti cotropic
hypertrophy.

hormone which causes adrenal

Goetsch (1940) attempted to implant adrenaline pellets on

7.

the thyroid of guinea pigs but was not successful.

Using adrenaline in

oil, rabbits were injected daily for 71 days and differences in thyr oid
mitochondria were observed in the experimental and cont rols.
in the size of the mitochondri a was deemed stimulat ion .

The change

Five years

earlier Richter (1935) s t udied the effects of thyroid treatment on the
production and discharge of adrenaline.

This i nvestigation demons t rated

the increase in synthesis and discharge of adrenaline followed by adrenal
exhaustion.

Splanchnic sectioning did not alter the effect and thyroid-

ectomy resulted in rapid formation of adrenaline but no discharge of the
hormone.

Insulin increased the secretion of adrenaline leading to ex-

haustion.
The scope of thyroid investigations has been kaleidoscopic.

At-

tempts to correlate its activity on the tissue level have taken many
tangents.

There has been no formalization of approach and therefore

the problem has been attacked from various directions.

The results of

the experiments previously cited may have been influenced by oral feeding (Barker, 1951).

The marked weight loss following the feeding if

diets containing 0.1 to 1.0 percent desiccated thyroid plus added vitamins
disturbs the caloric balance.

As the hyperthyroid state develops, the

amount of thyroid ingested is increased leading to liver damage (Frazier,
1935; Haban, 1935 and Bartlett, 1938; cf. Barker, 1951).
Interest in enzyme interactions led to an investigation by Bacq
(1936).

This investigator found a prolongation of responses to sym-

pathetic nerve stimulation after pyrogallol administration.

The ef -

fect was attributed to the auto-oxidant properties of the catechol.
Barker (1951) states that liver cytochrome oxidase, succinic oxidase,
and d-amino acid oxidase systems were more active after the administra-

a.
tion of thyroid.

Dehydrogenase activity was reduced by thyroidectomy and

had the opposite effects.

Blaschko and Schlossman (1940) corroborated

these findings with the specification that cytochrome oxidase oxidation
of adrenaline is augmented by thyroxine, dried thyroid or the thyroid
stimulating hormone (Tipton and Nixon, 1946).
Investigations into the effects of thyroid and MAO interactions
were reported by Spinks and Burn (1952).

They found that MAO activity

was increased in thyroidectomized rat s .

A decrease in the ac tivity of

MAO activity followed thyroid f eeding .

Spi nks and Bur n a lso postulated

that amine oxidase levels were respons i ble for the reduction of adrenaline hyperglycemia with thyroidectomy and the elevation of adrenaline
hyperglycemia with thyroid feeding.
Zile and Lardy (1959) using rat liver mitochondria, demonstrated
that thyroid feeding decreased MAO activity but no observable change was
elicited after thyroidectomy.

Using thyroid in vitro, no direct inhibit-

ing effect could be shown manomatrically.

Further work by Zile (1960)

and Dubnick et al. (1960) demonstrated the effect of thyroxine and
other thyromimetic compounds on heart MAO activity.

Zile contends

that no measurable change of heart MAO activi ty was apparent in the
rat.

Changes in the brain were inconsis e nt.

no further decline in MAO was demonstr ated.

Upon doubling the dose,
Dubnick et al. (1960)

demonstrated a decrease in br ain MAO activity fol lowing thyro i dectomy.
The work of Novick (1961) substanti ated the experi ments of Zile and
Lardy (1959) in one aspect.

Using manomet r i c methods, Novick reported

that a 2 percent des i cated thyroi d diet r educed the MAO activity of
the livers by 50 percent.

This i nvestigat or 's experimental results

with heart MAO activity appar ently conflicted with those of Zile (1960).

9.

Thyroid feeding or administration of L-triiodothyronine did not decrease
MAO levels in the heart but instead increased the content.

Novick also

observed oxygen stimulation of various substrates to different degrees.
In 100 percent oxygen the uptake of oxygen was elevated by a factor of
2.

Serotonin, the substrate used by Zile (1960), was shown to be stim-

ulated in a total oxygen atmosphere by a factor of 1.4.

-

Skillen et al. (1962) made an important contribution by evaluating the effect of thyroid on MAO in male and female rats.

Male rats

possess greater heart MAO activity than females with no difference in
5-hydroxytryptophan decarboxylase or S- hydroxytryptamine levels.

Thyroid

feeding did not lower heart MAO in males but did elevate MAO levels in
females.

Chemical thyroidectomy, by the administration of propyl-

thiouracil, decreased male heart MAO activity .but did not alter female
activity.

This work skillfully correlates the work of Novick, Zile,

and Zile and Lardy.

Novick used mixed sexes; Zile and Lardy used male

rat . •
Other paradoxical events have contributed to the argument.

Five

hours after the administration of an MAO inhibitor, trans-2-phenylcyclopropylamine, norepinephrine levels were shown to be falling at a
time of complete MAO inhibition.

If a feedback mechanism to arrest

further synthesis becomes operable, there should be a leveling of norepinephrine levels but not a decline.

The alternative would be another

pathway of metabolism such as the catechol-0-methyl transferase (CDMT)
system as suggested by Axelrod (1957).
Ostensibly, MAO activity is modified by MAO inhibitors and the
amount of inhibition of MAO should correlate with the effect, but there
are dissenting views.

Euler (1955), Corne and Graham (1957), Axelrod and

10.

Larouche (1959), Axelrod et al. (1959), and Kopin (1960) suggest that
deamination is a minor pathway of administered catecholamines.

The fact

that CX>MT is mainly responsible for the degradation of epinephrine is a
view held by Axelrod (1957) and Axelrod and Tomchick (1958).

Grieseme.r

et al. (1953) and Brown and Gillespie (1957) believe that exogenous and
endogenous catecholamines are not prolonged in their action by MAO inhibitors.

They further state that more than one- half of the epinephrine

and norepinephrine is conv rted to metanepbrine or normetanephrine in
two minutes.

This implicates CX>MT as the enzyme which terminates most

of the activity of epinephrine and norepinephrine.
Axelrod et al. (1959), with infusion techniques. found that the
concentration of epinephrine localized in heart, spleen, adrenals, and
pituitary exceeds plasma levels several told.
rine levels were lower than the plas1na.

Muscle and brain epineph-

Metanephrine concentration was

comparable to epinephrine in all tissues, but higher in skeletal muscle.
When epinephrine was injected rapidly, the concentration of metanephrin
was much higher than epinephrine particularly in heart, lung, liver and
muscle.

In the pituitary, however, epinephrine levels were higher than

metanephrine levels.

Plasma al o exhibited higher metanephrine levels

with a trace of mandelic acid derivatives.

Since epinephrin~ was found

to be in lower concentrations after rap d injections, it was postulated
that epinephrine was bound after fast injections and then released for
metabolism.

Bpinephrine's biphasic degradation .was also noted.

The

first phase, which was rapid, is explained by diffusion into the tissues
and 0-methylation.

The second phase consists of the release of epineph-

rine from the binding sites and concomitant metaboli m.

This information

suggests strongly that o- methyl tion is a major degradative pathway for

11.

the catecholamines.
If MAO is considered a secondary path of metabolism of the catecholamines. MAO inhibitors would not be expected to elevate catechol-

amine levels significantly.

Reports of increased levels of catechol-

amines and the potentiation of effects of catecholamines have been made
by Pletscher (1957), Glylys et al. (1959), and Burford et al. (1960).

Serotonin levels have been
ible inhibitor, phenelzine.

incr~ased

after 24 hours us ing an irrevers-

When these levels receded, a dose of a

short acting inhibitor, harmaline, produced a booster effect (Dubnick
et al., 1962).

It may be questioned as to whether 100 percent

hibition had been achieved.

in~

Spector et al. (1960a) consider the rise

in serotonin with phenylalkylhyarazines unusual when compared with
iproniazid, since the amount of MAO in the brain is almost completely
inactivated.

The possibility of inacessibility of MAO to iproniazid

is considered primary.

The function of MAO is seen as an intracellular

deactivation mechanism for the amines in neurons to prevent spillage
onto receptor sites.

If the MAO is located in the same neuron as nor-

epinephrine, epinephrine, and serotonin, the amines are limited in action when storage sites are saturated.

The delay in effect of MAO in-

hibitors after blockade is ostensibly caused by the lag in the filling
of the storage sites and the eventual overflow onto the receptors.

The

pharmacological effect is seen only after the amines have reached a
maximal concentration.

The suggestion of Dubnick et al. (1962) is somewhat contradicted
by an earlier report of Weissbach et al. (1961), postulating the presence
of variable low levels of MAO in the brain which are insensitive to MAO

inhibitors.

The enzyme can catalyze the fortnation of

S~hydroxyindole

cetic acid.
'lb.e fact that the physiologic 1 action of MAO inhibitor• are not
manif et unleaa th

nz)'ll\ 11 inhibited 85 percent or more ha b n re-

ported by G y and Pl tacher (1961) and Cheaain et al. (1959).
MAO la

Since

lieved to be stored in granuleft (Gi rman and Schanberg, 1958;

Walaaeaek and Abood, 1959), it i
formation.

poa ibly protected trom enaymic tr

Gey and Pletacher (1961) auggeat that HAO i

pres nt in

ne ~

ex~

c a in rat brain and the function of the enzyme ia to inactivate fr
amines rather th.an to regulate total amin
Major actions

~hich

1.

do not involY inhibition of d amination hav

been attt•ibut d to MAO inhlbitora.

'l'he "true" action ot! MAO ia.b.:lbitor.

was emphasiz d by O en nd Brickaon (1960), who observed the f lling of
norepinephrln

le•al1 after MAO had b en completely blocked.

Axelrod

et al. (1961) uaing long and hort acting MAO inhibitors and tritiumw
labeled epinephrine demonstrated that epinephrine haa a dipha1ic
degradation curve after treatment with rea rpine.

The MAO inhibitor•

did not vary the rapid phase of degradation but xtended the slow
degradation curve.

Axelrod int rpreted thi1 as an inhibition of
'

reeerpi • release ot catechol mine• from their binding sites.

Spector

et al. (1960), uaing a blood platelet 1y1t m, refuted r serpln block
ae a mechanism of action of MAO inhibitor1.
Th

fact that thyroid reinforce• the ffecta of

pinephrine

(Thibault, 1948) and reduces the MAO 1 vela in varioua ti11u a display•
the importance of thia interr lationahip.

Epinephrine haa b n shown

to stimulate th release of triiodothyronine and

t

traiodothyronin

in

dogs u1ing th 1 v 1 ot prottin bound iodine (PDtl31) in th thyroid
vain aa criteria (Ackerman and Arone, 1958).

1ncrea1•

in PBil31 l vela

after injections of 6pinephrine ranged from l.S to 17.l ti.mes the control
The thyroid stimulating hormones increased PBt 131 secretion 7.4

values.

to 18.9 times that of the controls.

Increases in PBI131 were comparable

in the hypophysectomized dog indicating a direct e feet on the thyroid.

The fact that Axelrod et al. (1959) observed that the highest amount of
brai.n epinephrine is found in the pituitary gives an indication of the

complexity of the modifying influences on the pituitary hormonal picture.
With the advent of the psychic energizers, an enigmatic response
was noted by Kline (1961) • . The combination of the psychic energizer
with thyroid extract produced a retardatioa and apathy in depressed
patients.

The basis 'f or this action is not kno'Wll and generally unexplored.

Ill.

A.

lNVESTIGAnON

Objectives
The tact th t thyroid extract and MAO inhibitors combined cause

a retardation in the mental h alth of the depressed patient has been
considered a paradox since each singly produces the opposite effect.
There has not been an attempt to relate the cause of the retardation and

apathy with locomotor activity and enzyme levels.
Specifically, the object of this investigation is to analyze the
unpredictable responses observed when thyroid and MAO inhibitors are
minist red concurrently.

ad ~

1

L&comotor activity experiments were performed

on mice after the administration of thyroid, M0911. and combined thyroid
and M0911.

F\lrthermore, MAO enzyme activity was determined at the con..

clu1ion of the locomotor studies.

The results of these experim nts

showed the role of MAO in apathetic response associated with MAO inhibitors and thyroid combined therapy.
Locomotor relationships were evaluated by the use of actophotometers.1 The actophotometer ia suited for locomotor studies since. it
records animal movements by a light beam interruption technique.
light beam with a red filter energize

photo-electric cells.

A

The an-

imals ' movements will interrupt the beam indicating a pulsating voltage.
The number of the pulsations is counted and is used as an index of
activity.

Thi technique offers n indirect qu ntitation of central

nervous system activity.
B.

Materials and Methods
1.

1.

Group Selection and Actophotom ter Calibration:

Actophotometer, Metro Industries, Long Island City, N.Y.
14

15.

Male mice weighing 19-25 grams were placed in each of four actophotometers, distributed 6, 5, 4• and 3 in each cage.
at specific time intervals up to 2 hours .

Counts were taken

These counts were recorded and

plotted on semilog paper to determine the ratio of change during each
time interval.

The relationships showed that 3, 4, S , or 6 animals could be

used.

Four animals were selected because of convenience in ease of

handling.
The actophotometers were located in a soundproof room and counts
were obtained in total darkness.
the same time each evening.

The

All counts were taken at approximately
temperature variance of the room from

eoop. was mi.niinal.
Calibration of the actophotometers was accomplished by rotating

an implement around the inner circumference in such a manner that S
rotations produced a count of 60.

Identical counts were obtained by

the adjustment of the sensitivity.
2.

Drugs:
Forty-eight male mice were divided into three sections of six-

teen animals.

Bach section was subdivided into 4 groups of four animals

designated I, II, III, IV.

One group in each section, or a total of

twelve animals, served as controls.
iccated thyroid intraperitoneally.

Section I received 1 mg/kg desSection II 'and III received 6 mg/kg

N-benzyl-N-methyl-2-propynylamine hydrochloride (M:>911) a non-hydrazine
MAO inhibitor, and combined administration of desiccated thyroid and
M:>911 respectively.l

1.

Injections were administered daily.

The structural formula for M0911 appears in the Appendix.

16.

Desiccated thyroid was suspended in physiological saline and administered intraperitoneally.

Kl911, which is very soluble (1.6 g/ml)

in water, was also administered intraperitoneally.
sham injections of the vehicle.

Controls received

Upon introduction of combined therapy,

the control mice were injected with an amount of water equivalent to
the total fluid intake of the mice.
3.

Locomotor Determinations:
Four male mice were placed in each of four actophotometers.

After

equilibrating for 15 minutes, the counters were activated and counts
taken at 5, 10, 20, 30, 60, and 120 minutes.

The temperature of the

activity room was recorded throughout the experimental period by utilizing a Tempscribel thermometer.
The basis of comparison of the two groups, the experimental and
controls, was the student "T" test as modified by Snedecor (1956).

The

formula utilized is:
n(n - 1)
~2

or

n 1n2 Cn 1 + n2 - 2)
(n1 - n 2 ) ~x2

i1 -

x2 designates

the difference between the two group means.

~x 2 is the pooled sum of the squares.

Actophotometer experiments were initiated 24 hours after injection
of a specific drug.

Drug dosages were administered following the removal

of mice from the actophotometers.

1.

Activities were tested daily 24 hours

Tempscribe, Bacharach Industrial Institute, Pittsburgh, Pa.

17 • •

subsequent to injections.

Sham controls were used throughout the period

of investigation.
4.

MAO Analysis:
MAO activity was determined by the method of Creasey (1956) and

the mitochondrial-microsomal preparation according to Hawkins (1952).
Hawkins (1952) indicated that two thirds of the MAO activity is present
in the mitochondria and the remainder is present in the microsomes .
Male mice were decapitated and the brains and livers were removed.
The tissues were frozen by immersion into a freezing slush of dry ice
and trichloroethanol.

The tissues were kept in a freezer and MAO ac-

tivity was analyzed within 30 days.
Crushed ice was used throughout the period of preparation of
mitochondria and microsomes to obtain maximum yields of MAO activity.
All implements utilized in preparing the tissues were placed in crushed
ice.
The frozen tissues were weighed on a tissue balance 1 and minced
with scissors while in isotonic sucrose (0.2SM) and the resulting pulp
was transferred to a homogenizing flask.

An amount of isotonic sucrose

was used in a ratio of 6:1 with the tissue.

The homogenates were pre-

pared with a teflon and pyrex homogenizer.2

The homogenate was then

transferred to a refrigerated centrifuge 3 and centrifuged at 755 x g
for 10 minutes.

This procedure sedimented the unbroken cells, the

incompletely homogenized cell fragments, the nuclei, and red blood
cells.

1.
2.
3.

Vereenigde nraadfabrie Ken Nijmegen, Holland.
Tri R Homogenizer, Tri ~R Instruments, Jamaica, N. Y.
Servall Refrigerated Centrifuge, Model RC-2, Ivan Ser.vall Inc., Norwalk, Conn.
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The supernatant containing the soluble cell constituents
ing the microsomes and mitochondria was decanted.

includ~

This fraction was

centrifuged at 22,000 x g for 45 minutes in order to separate the
soluble proteins from the formed elements.

The pellet formed con-

sisted primarily of the mitochondria and microsomes.

The supernatant

was carefull discarded and cold sucrose added so that the mitochondri.amicrosome mixture was equivalent -to 200 to 350 mg of fresh tissue.

MAO activity was determined by use of the Warburg apparatus. 1
The main compartment of the conical flask contained l ml of the

pro~

tein, 0.2 ml of 0.24M sodium phusphate buffer (Dawson, 1959) pH 7.3,
and 0.2 ml neutralized semicarbazide.
final volume to 2.S ml.

Water was added to bring the

The side arm contained 0.4 ml of o.OSM

tyramine hydrochloride as the substrate or 0.4 ml water in the
trots.

con~

Carbon dioxide absorption was facilitated by 2M KOH in the

center well.

Filter paper with accordian folds was placed in the

center well extending approximately 1-2 mm above the lip to increase
the surface area of the KOH.

The analysis was performed at 38°

Centigrade and the preparation was gassed with oxygen (2 liters/min.)
for 2 minutes.

Five flasks were -used per assay consisting of three

experimental , two controls and one

thermo~barometer.

Readings were

taken at four minute intervals .and total time was 28 minutes.

Ex-

trapolation of time to one hour was achieved by use of the derived
equation.
MAO catalyzes the reaction:

1.

Bronwill Scientific Inc., Rochester, N.Y.
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Theoretically one molecule of oxygen is absorbed for each mole of substrate deaminatedo

The work of Kohn (1937), Pugh and Quastel (1937),

and Luschinsky and Singher (1945), demonstrated that crude MAO preparations contain peroxidases and aldehyde oxidase which elevate the
retical values of MAO activity.

theo~

Creasey (1956) demonstrated that

semi~

carbazide reduces the spontaneous oxidation of the aldehyde (parahydroxyphenylacetaldehyde).
thi.s system.

Aldehyde oxidase was found not to affect

The schematic representation of the oxidation of tyramine

substrate is depicted in Figure l .
Total respiration was determined by the method of Umbreit (1957).

IV .

RESULTS

All tables and figures are contained in this section.
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TABLE 1
Oxygen Uptake of Livers Treated with Thyroid, M09ll, and Combined M0911 and thyroid
Time

)11 02 Uptake
Thyroid Section
Control

pl 02 Uptake
M0911 Sect1on--Contro1

)ll 02 Uptake
M0911-Thyroid
cOntrol

4 min.

11.3

12.4

0.22

12.8

3.9

17.0

8 min.

18.6

19.9

1.2

21.6

6.4

24.6

12 min.

25.7

26.5

2.9

28.3

9.2

29.9

16 min.

32.l

31.8

1.7

36.2

10.6

37.0

20 min.

37. 7

36.4

1.4

42.9

12 . 4

41 .8

24 min.

40.6

42.l

2.1

50.0

13.6

47.5

28 min.

45 .6

45 .4

3.0

55.6

20.1

54.8

"'......

•

TABLE 2
Brain Respiration
K>9l-1----~-----

pl 02/hr.

Percent
Decrease

Control

12.6

0

Control

Group I

2.4

81

GrOUf l

Group II

9.6

24

Group Ill

Group III

16.4

.. 30

Thyroid

Section

Group IV

)(11

02/hr.

+.

Percent
Decrease

ThyroidM0911

pl 02/hr.

Percent
Decrease

49.6

0

Control

22.6

0

2.8

100

Group I

3.9

83

1.3

97

Group III

+ 3.4

100

12.2

75

Group IV

5.2

77

N
f\,)

•

TABLE 3

Average Percentage Change of Actophotometer Counts of Mice Treated with Desiccated Thyroid

Control

15 mln.*

SD

t

p

25 mln.

SD

101

16.6

-

-

83

25.6

108

Group I

29.9

0.638

>o. so·o

t

p

0.400
96

35.l

0.928

0.200

14.8

0.177

'>0.500
0.400

43.5

1.186

0.200

SD

t

p

0.05

-

Group II

71 .

10.6

2.544

0.025
0.400

80

Group III

89

30.7

1.087

0.200

102

t

p

1i5 min;--- - ----SD

Control

119

22.6

-

Group I

97

30.5

0.851

121

29.8

0.053

Group__!!
Group III

*

---·-----

-

-

I

-- - - - - --90 tiii.n.

89

18.3

0.400

83

19.8

0.684

>o.5oo

.> 0.500

93

26.3

0.150

-==so. 500

109

76.2

0.800

o.4oo

o.soo

-

o.500
98

38.2

represents mid point of time interval
" t" - t value

0.812

-

0.400

o.soo

-

IV

SD - Standard Deviation
P - P value

VI
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TABLE 4
Average Percentage Change of Actophotometer Counts of Mice Treated with M0911

Control
Group I

Is m.ln.*

SD

t

p

25 min.

SD

93

17.6

-

-

93

12 .4

101

21.2

0.141

> o.500

t

0.400
98

16.0

1. 106

0.200
0.400

0.400.

-

p

Group III

93

15 .9

1.106

0.200
0.400

99

15.7

1.264

0.200

Group IV

100

23.6

1.050

0.200

9ll.

23.1

0.340

>o.soo

t

p

- · 90 -nif.n.

SD

t

-

104

49. 7

4.5-miii; -

Control

86

sn- 20.6

-

p

0.500·

-

Group I

92

21.0

0.705

0.400
0.200

103

15.l

0.360

>0.500

Group III

96

14.6

1.665

0.100

98

9.1

0 .186

>0.500
0.400

Group IV

87

24.2

0.145

> o.500

93

37.2

1.012

0.200

*

--- - - - - - - - - - - - -

represents mid point of time interval
""t
t value
0

'

-

-

-

SD - Standard Deviation
P - P value

.
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TABLE 5

Average Percentage Change of Actophotometer Counts of Mice Treated with M0911 and Desiccated Thyroid
is mrn.*

SD

t

p

25 min.

SD

Cont.r ol

94

14.0

-

-

99

11 . 7

Group I

86

10.6

0.253

106

47.2

0.5.56 >0. 500

103 ,;,

13.'6

0.768

0.400
o.4oo

89

21.9

0.99

0.200

SD

t

p

;>0.500

....

'

.....

t

p

o.soo

Group I l l

88" ·

13 .8

0.354

~o. soo

Group IV

90

21.5

0.175

o.soo

SD

t

p

-

104

28.8

o.soo

105

74 . 8

0.0919 > o.soo

> o.5oo

93

B.5

0.347 >0.500
0.100

79

35.7

liS -inrn;- ---

Control

107

26.4

-

Group I

116

77 . 5

0.115

95

9.1

0.415

Group Ill

.>

-- - --- -- - 90--aiin.

0.100
~

Group IV

84

30.7

-

1.93

-

o.oso

1.89

o.oso

.""

IJt

* represents mid point of time interval
"t" - t value

SD - Standard Deviation
p - P value
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Fig. l.

Tyramine deamination by monoamine oxidase.
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Fig. 2.
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Oxygen uptake of liver homogenates from mice treated with thyroid.
Each point represents the average oxygen uptake of 12 mouse
liver homogenates analyzed manometrically. The calculated
equation for the regression line is Ye = 4.4 + l.6X by the
method of least squares.
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Fig. 3.
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Oxygen uptake of liver homogenates of the non-treated mice used
in parallel studies with thyroid.
Bach point represents the average oxygen uptake of 4 mouse liver
homogenates analyzed manometrically.
The calculated equation for the regression line is Ye
l.6X by the method of least squares.
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Fig. 4.

Oxygen uptake of liver homogenates from mice treated with M:>911.
Each point represents the average oxygen uptake of 12 liver
homogenates analyzed manometrically.
The calculated equation of the regression line is Ye
0.089X by the method of least squares.
I
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s.

Oxygen uptake of liver homogenates of the non-treated mice used
in parallel studies with M0911.
Each point represents the average oxygen uptake of 4 mouse liver
homogenates analyzed manometrically. The calculated equation for
the regression line is Ye
4.0 + l.9X by the method of least
squares.
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Oxygen uptake of livers treated with M>911 and thyroid.
Bach point represents the average uptake of 12 mouse liver
homogenates ana·l yzed manometrically.
The calculated equation for the regression line is Y
0.62X by the method of least squares.
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Fig. 7.

Oxygen uptake of liver homogenates of the non-treated mice used
in parallel studies with M0911 and thyroid.
Bach point represents the avet'l!l.ge oxygen uptake of 4 mouse liver
homogenates analyzed manometrically.
The calculated equation of the regression line is Ye
l.77X by the method of least s quares.

= 6.8
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a.

Relationships of locolllCl)tor activity of nor11al mice and
thyroid treated mice.
The values of the abscissa represent time. The ordinate
values indicate the per~entage change of activity variance
from the control depicted as 1003.
The interrupted lines are the standard deviations of the
controls. Solid bars are the standard deviation of th~
experimental.
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Relationships of locomotor activity of normal mice and
thyroid treated mice.
The values of the abscissa represent time. The ordinate
values indicate the percentage change of activity variance from the control d~picted as 100%.

nt.e interrupted lines are the standar d deviation of the
e~perim.ental.
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Fig. 10.

Relationships of locomotor activity of normal mice
and thyroid treated mice.
The values of the abscissa represent time. The
ordinate values indicate the percentage change of
activity variance from the control depicted as 100%.
The interrupted lines are the standard deviations
of the controls. Solid bars are the standard
deviation of the experimental.
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Relationships of locomotor activity of normal mice
and M0911 treated mice.
The values of the abscissa represent time. The
ordinate values indicate the percentage change of
activity variance from the control depicted as 1003.
The interrupted lines are the standard deviations of
the controls. Solid bars are the standard deviation
of the experimental.
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Relationships of locomotor activity of normal mice and
M0911 treated mice .
The values of the abscissa repre sent time. The ordinate
values indicate the percent age change of activit y variance from the control depicted as 100%.
The interrupted lines are the standard deviations of
the controls. Solid bars are the standard deviation
of the ~xperimental.
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Relationships of locomotor activity of normal mice
and M0911 treated mice.
The values of the abscissa represent time. The
ordinate values indicate the percentage change of
activity variance from the control depicted as 1003.
The interrupted lines are the standard deviations
of the controls. Solid bars are the standard deviation of the experimental.
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Fig. 14.

Relationships of locomotor activity of normal mice
and M091.l -thyroid t.reated mice.
The values of the abacissa represent time. The
ordinate values indicate the percentage change of
activity variance from the lontrol depicted as 1003.
The interrupted lines are the standard deviations of
the controls. Solid bars are the standard deviation
of the experimental.
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Fig. 15.

Relationships of locoaotor activity of normal mice
and M0911-thyroid treated mice.
The values of the abscissa represent time. The
ordinate values indicate the percentage change of
activity variance from the control depicted as 1003.
The interrupted lines are the standard deviations of
the controls. Solid bars are the standard deviation
of the experimental.
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Fig. 16.

Relationships of locomot9r activity of normal mi ce
and M09111othyroid treated mice.
'
The values of the abscissa represent time. the
ordinate values indicate the percentage change of
activity variance from the control depicted as 1003.
The interrupted lines are the standard deviations
of the controls. Solid bars are the standard devia·
tion of the experimental.

V.

DISCUSSION

Thyroid administration elicited :changes in locomotor activity
but not to any great extent.

In group I (Figure 8), the 10-20 minute

average was 7 percent above that of the control which was not statistically significant.

This indicates that locomotor activity of the control

and the experimental at this time interval were not significantly different.

The actophotometer counts which are an indication of central

nervous system activity did not deviate significantly from the controls
throughout the various time intervals.
Comparisons of the

t~

remaining experimental groups yielded the

same information except in one instance.

In the first time interval

the activity in group I I (Figure 9) was depressed.

Following this de-

pression, the activity returned to values within the control levels.
Since the depression was not apparent in the other experimental group
and did not persist for a reasonable time interval, the interpretation
that thyroid administration was the causative factor is not justified.
This transient effect is apparently caused by a lag in

equ~libration

of this group of animals to the actophotometers or by the increased
social activity of the mice.
Generally, thyroid at .the dosage employed did not increase

no~- de

crease locomotor activity as measured by actophotometers (see Table 3 and
Figure 10).

The thesis that thyroxine acts by uncoupling oxidative phos-

phorylation (Lipmann & Dutoit, 19Sl; _Matuis & Hese, 1951; and Lardy &
Maley, 1954) with concomitant production of a higher metabolic rate may suggest that thyroid's systemic effects should produce a measurable rate of decreased locomotor activity.

Uncoupling oxidative phosphorylation re-

leases the regulatory mechanism for maximum utilization of energy rich
42
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bonds and prevents ADP rephosphorylation.
Administration of MJ911 did not increase locomotor activity
(Figures ll-13).

During all time intervals the response of the experi-

mental animals was not different than that of the controls (see Table 4).
Wiegand and Perry (1961) stated that no behavioral changes were elicited
by treatment with M>911 alone.

Upon addition of DL-dihydroxyphenylala-

nine {DL JX>PA) after pretreatinent with M09ll. an increase in activity
and aggressiveness was noted.

They suggest that the increased ac-

tivity is due to increases in dopamine or norepinephrine.

Carlson et

al. (1959) (cf. Wiegand and .Perry, 1961) agree with this hypothesis
after measuring dopamine and norepinephrine levels in mice 6 hours
after MAO inhibition.
The latter proposal .is contradicted by the evidence of Everett
and Wiegand (1961).

These investigators demonstrated a gradual increase

in central amines along with increasing motor activity and aggressiveness.
be

Their effects were also augmented after giving DOPA.

This may

the pivotal statement.
The postulated correlation of increased locomotor activity and

aggressiveness with dopamine or norepinephrine appears reasonable, but
the fact that precursors must be added to initiate increased activity
indicates that the rate of -synthesis of the catecholamines is not sufficient to elevate norepinepbrine levels or that inhibition of MAO
does not affect catecholamine metabolism to a significant degree in
brain tissue.

If this hypothesis is accepted then the lack of loco-

motor activity of the experimental animals versus the controls is not
enigmatic.
Taylor and Krause (1962) have invalidated arguments concerning
the possibility that M0911 does not cross the blood brain barrier.

44.

c14-labeled

N>911 was found in adequate concentrations in the brain of

rats and dogs, with detectable amounts up to 48 hours in rat brain.

The

extrapolation of this information to mice would be in order.
There are other effects of M0911 which could modify its total
activity.

These diverse effects are present in other MAO inhibitors

of different structure.

Rorowitz and Sjoerds111a (1961) demonstrated a

decrease in sympathetic nerve activity.

Costa and Brodie {1961) also

noted similar effects by pretreating with M0911 and then following with
Ford (1961), and Decosta et al. (1961).

The mitigating influences of

these physiological responses on .gross locomotor activity are apparent.
Any of these alone or in combination could reduce a gross effect to
the limits of a measuring instrument.
in this experiment.

These factors were not controlled

Efforts to control these factors would present

serious problems in evaluating the results of in vivo locomotor studies.
Combined therapy of thyroid and MAO inhibitor did not signif icantly alter locomotor activity {see Table 5 and Figures 14-16).

The

response noted by Kline (1961) of retardation and apathy was not dµplicated with mice.

Since the retardation has been demonstrated only

in depressed humans, a similar alteration of .the psyche must be induced
in experimental animals for duplication of this response.

Tl\ere has

been no documentation of normal patients responding to thyroid and MAO
inhibitor medication in this manner.
In all of the actophotometer studies, fluctuations from the control values were evident on particular days.

None of the departures

from the normal or control values were significant.
established and the fluctuations were random.

Trends were not

Since all animals i.n a

45.
particular section were handled under the same conditions, it is apparent that the drugs did not alter locomotor responses in a signif icant manner.
The method of Creasey (1956) and Hawkins (1952) was satisfactory
in measuring MAO activity manometrically.
oxygen uptake of mice liver mitochondria-microsome as a measure
of MAO activity after thyroid treatment was linear with time (Figure 2).
The coefficient of correlation was 0.99, indicating a high degree of
linear association.

The coefficient of determination indicates that

97 percent of the variations occurring in

o2 uptake can be explained

on the basis of the linear regression of oxygen uptake with time.
Total oxygen consumptions was 45.6 pl for 28 minutes (Table 1).
Respiration of control .mice liver mitochondria for the thyroid
experiment also indicates linearity with time (Figure 3).
efficient of correlation was 0.98.

The co-

Variation of the dependent vari-

able could be explained by the variation of the independent as demonstrated by the calculated value of o.96.

Oxygen uptake was 45.4 pl

for 28 minutes (Table 1).
W~th

the aid of covariance analysis (Snedecor, 1956), the prob-

ability that the two regression lines are in fact the same line is 99
percent.

Since these lines also possess the same slopes, this suggests

that the regression lines are not different.

The total oxygen uptake

per hour for the thyroid treated animasl would be 100.4 pl

o2 • The

experimental consumption was not significantly different from the control value of 101.1 pl

o2 •

These values do not agree with Spinks and Burn (1952), Zile and
Lardy (1959).

Skillen et al. (1962) found that thyroid decreases MAO

activity in rat liver.

Novick (1961) also found that thyroid decreases

46.

MAO activity 50 percent below that of controls.

Zile (1960) found in-

significant changes in brain and heart MAO activity with thyroxine and
related compounds and that increased dosages did not elicit a more profound effect.
One theory concerning the mechanism of action of thyroid on MAO
is that thyroid decreases enzyme levels indirectly.

Zile and Lardy

(1959) suggest that thyroid regulates the biosynthesis of MAO or controls the enzymes that govern the activity of MAO in the liver.
Westermann (1956) found an increase in MAO following thyroid
feeding in rat livers.
It is apparent that no definite statement can be made concerning the effects of thyroid on MAO activity in rodents.

Barker's (1951)

observation that thyroid feeding even with supportive vitamin therapy
produces changes in the liver not attributable to thyroid alone may
have valid application.

If there are changes in the physiology of the

liver, the differences in MAO activity may not accurately reflect

change,~

produced by drug administration.
Mice liver mitochondria-microsomes, removed from M0911 treated
animals, showed reduced respiration linear with time (Figure 4).
oxygen uptake was 5.6 pl/hr.

Total

The coefficient of correlation was 0.79

and the coefficient of determination 0.62.

The latter coefficient size .

is indicative of influences of factors other than the independent variable influencing the regression line.
The oxygen uptake by the control animals was also linear (see
Figure 5).

The coefficient of correlation was 0.93 constituting an ex-

cellent correlation.
relatively small.

The unexplained variation was 13 percent which is

47.

Reduction in liver MAO activity by M0911 has been reported by
Taylor et al. (1960).

The results of this experiment corroborate

Taylor's work.
The decrease in MAO activity

ot mice liver mi tochondira was l.8

times that of the controls (Table 1).

It is apparent that M0911 is a

powerful MAO inhibitor and that significant decrease in MAO levels can
be achieved and maintained by daily injections.
Combined therapy of M0911 and thyroid reduced MAO activity of
livers significantly over the controls (see Figure 6).
of treated livers was determined to be 38 pl
the control value of 113 pl

o2

Total activjty

o2 per hour as opposed to

per hour (see Figure 7).

Comparing the

results of combined therapy with K:>911 therapy , a six fold increase in
MAO activity is observed (see Table 1).

This suggests that thyroid

antagonizes the effects of M0911 in liver.
The fact that thyroid elicits no change in MAO activity but suppresses the total effect of M:>911 may indicate a specific mechanism of
action.

Thyroid, a metabolic stimulator, apparently causes an in-

creased turnover of constituents in the cell .

The ability of an exo-

genous inhibitor of an enzyme system to exercise its usual effect may
be reduced .

This may be caused by increased synthesis of the enzyme

or the inability of the inhibitor to reach the substrate in an effective concentration.

The result would be increased activity of the

enzyme when combined thyroid and MAO inhibitor therapy is utilized.
Brain mitochondrial .MAO activity after thyroid administration
was variable

[
(~able

2).

Enzyme levels were lower in two groups with

percentage decreases of 81 percent and 24 percent.

The third experi-

mental group showed a 30 percent increase in MAO activit y.

'lbe re-

48.
fractory response of the latter group cannot be explained in terms of
penetration of the aeblood brain barrier.. by thyroid since two groups
did show definite decreases in MAO activity.

These results agree with

Zile (1960), who stated that the changes in MAO activity in brain after
thyroid feeding were insignificant and inconsistent.
There is no reason to suggest that the increase in MAO activity
is an artifact.

Apparently, this is an individual response with obscure

prerequisite cell constituents which would predetermine whether an increase or decrease in MAO activity is observed.
M'.>911 therapy decreased Ml\0 activity in three experimental groups.
Several investigators have observed a decrease in brain MAO activity
after M0911 therapy, including Taylor et al. (1960; l960a), Wiegand
and Perry (1961), and

Baronde~

(1962).

In our investigation enzyme

activity declined 100 percent, 97 percent and 75 percent of control
values.

This indicated that there is no impediment for access of M0911

to active sites of enzyme inhibition in the brain.
Thyroid and M09ll therapy .did not differ from M0911 alone in its
effects on MAO depletion in brain tissue.

The experimental groups

sho'Wed decreases of 100 percent, 83 percent and 77 percent in activity
(see Table 2).

It is apparent that no augmentation of effect or antag-

onistic response occurred at .this level.

Apparently, if any changes in

the metabolism of the catecholamines are to be shown, another enzyme
system, possibly the CDMT system, may be involved.
Since the brain is such a complex system, other modifications
in function cannot be overlooked.

Changes in other systems could ac-

count for the retardation and apathy observed in patients.

VI.

SUMMARY AND CX>NCLUSIONS

The interrelationships of thyroid, MAO, and locomotor responses
have been investigated.
Locomotor activity of mice was evaluated by the use of actophotometers.

The administration of thyroid, M0911, a MAO inhibitor,

and combined thyroid and M0911 therapy, did not alter spontaneous activity significantly.
The apathetic response was not produced in mice with combined
thyroid and M09ll administration.

Reasons for the lack of response by

the experimental animals were discussed.
MAO activity was measured manometrically using the Warburg apparatus.

MAO activity, measured by uptake of oxygen, was shown to vary

with the administration of thyroid, M0911, and combined thyroid and
M0911.

MAO activity could not be correlated with locomotor activity

since spontaneous activity was not affected by the administration of
the drugs employed.
Brain MAO activity did not show consistency after drug administration.

MAO activity decreased in two groups but increased in one

group after the administration of thyroid, !-1>911, and combined M0911
and thyroid.
M0911 treated animals exhibited no change in locomotor activity
but significant decreases of MAO .activity in brain and liver were observed.

Combined therapy of M0911 and thyroid resulted in an increase

in MAO activity in livers above that of M0911 and below thyroid administered separately.

The increase in MAO activity with combined therapy

indicates that thyroid antagonizes MAO inhibitors outside the central
nervous system.
49

so.
The central action of thyroid differs from its peripheral activity
in that brain mitochondria MAO w•s lowered on the average.

Apparently,·

thyroid action is nd:direct and the presence or absence of intermediates
determine observed

r~sults.

Since combination therapy did not show a aifference in MAO activity from M0911 therapy tissue, the response previously noted in humans,
retardation and apathy , could not be ascribed to changes in MAO activity in the brain.

VII.

REFERENCES

Ackerman, N. B. and Arons, w. L. : Effects of epinephrine and norep..
inephrine on acute thyroid release of thyroid hormones. Endocrinology !!!:723 , 1958.
Axelrod, J .: 0-Methylation of epinephrine and other catechols in vitro
and in vivo. Science .!!!!:400, 1957.
Axelrodt J. , Hertting, G. and Patrick, R. w.: Inhibition of H3 epinephrine release of monoamine oxidase inhibitors. J.P.E.T. 134:
325' 1961.
Axelrod, J. and Laroche, M. J.: Inhibition of 0-methylation of epinephrine and norepinephrine in vitro and vivo . Science .!,!2:800,
1959.
Axe lrod, J., and Tomchick, R. : Enzymatic 0-methylation of epinephrine
and other catechols. J. biol. Chem. ~:702 , 1958.
Axelrod , J., Weil-Malherbe, H., and Tomchick, R.: The physiological
disposition of a3 epinephrine and its metabolite metanephrine.
J.P.~.T. ~:251, 1959.
Bacq , z. M.: Recherches sur la physiologie et la pharmacologie du
systeme nerveux autonome. Arch. intern. physiol. ~:340, 1936 .
Barker , s. B.: Mechanisms of action of the thyroid hormone.
Review ~:205, 1951 .

Physiol.

Barondes, s. H.: The influence of neuroamines on the oxidation of
glucose by the anterior pituitary. I. the role of inonoamine oxidase. J . biol. Chem. !!!_:204, 1962.
Blaschko , H. and Schlossman, H.: The inactivation of adrenaline by
phenolases. J . Physiol. _2!: 130 , 1940.
Brewster, w. R., Isaacs, J . P., Osgood, P. F., King, T. L., and King,
A. B.: The hemodynamic and metabolic interrelationships in the
activity of epinephrine , norepinephrine, and the thyroid hormones,
Circulation ~:l , 1956 .
Brown, G. L. and Gillespie , J . s.: The output of sympathetic transmitter from the spl een of the cat. J . Physiol • .!.!!:81, 1957.
Bryant , J . M., Tonosdag, s., Schvartz , N., Fletcher , L., Fertig , H.,
Schwartz, M. s., Quan, R. B. F.: Antihypertensive properties of
pargyline hydrochloride. J . A.M.A • .!,Z!:406 , 1961 .
Buford , H., Leick , J ., and Welaszek, B. J .: Modification of the effects of biogenic amines on the heart by iproniazid. Arch. nit.
Pharmacodyn. ~: 39 , 1960.
51

52.

Burn, J. H. and Marks, H. P.: The relation of the thyroid gland to the
action of insulin. J. Physiol. ~:131, 1925.
Carlsson, A., Lindquist, M., Magnusson, T., J. Soc. Crem. Med. de Lisboa
131:96, 1959. (cited by Wiegand & Perry, 1961).
Chessin, M., Dubnick, B., Leeson, G., and Scott, c. C.: Biochemical
and pharmacological studies of ~ -phenylethylhydrazine and selected
related compounds. Ann. N. Y. acad. Sci. ~:597, 1959.
Corne, s. J. and Graham, J. D.: The effect of inhibition of amine oxidase in vivo on administered adrenaline, noradrenaline, tyramine,
and serotonin. J. Physiol. ~:339, 1957.
Costa, E. and Brodie, B. B.: A role for norepinephri ne in ganglionic
transmission. J. Amer. Geriatric Soc. 2:419, 1961.
Creasey, N. R.: Factors which i terfere in the manometric assay of
monoamine oxidase. Biochem. J. ~:178, 1956.
DaCosta, F. M. and Goldberg, K. I.: Depression of ganglionic transmission by M0911 (N-methyl~N-benzyl-2-propynylamine hydrochloride)
a non hydrazine monoamine oxidase inhibitor. Fed. Proc. ~:318d,
1961.
"Dawson, R. M. c., Elliot, D• .c., Elliot, w. R., and Jones. K. M.:
for Biochemical Research, Oxford University Press, London.

Data

:DUbnick, B., Leeson, G. A., and Leverett, a.: Monoamine oxidase (MAO)
activity in tissues of thyroidectomized rats. The Pharmacologist ~:
67. 1960.
Dubnick, B., ieeson, G. A., and Phillips, G. F.: An effect of monoamine
oxidase inhibitors on brain serotonin of mice in addition to that re~
sulting fn>t inhibition of monoamine oxidase. J. Neurochem. !:299,
1962.
Euler, u. s. von and Hellner-Bjorkman, S.: Effect of amine oxidase inhibitors on the noradrenaline and adrenaline content of cat organs.
Acta Physiol. Scand. ~: suppl. ,!1!:21, 1955.
Everett, G. M. and Wiegand, R. G.: Nonhydrazine monoamine oxidase inhibitors and their effects on central amines and motor behavior.
Biochem. Pharm. !:163, 1961.
Ford, R. V.: Clinical and pharmacological observations on a monoamine
oxidase inhibitor (pargyline hydrochloride) in hypertension. Cur~
rent Therap. Res. ~:378:82, 1961.
GiarmAn, N. J. and Schanberg, s.: The intracellular dist ribution of 5~
hydroxytryptamine (HT; Serotonin) in the rat brain. Biochem. Pharm~
acol. !:301, 1958.

53.

Goetsch, earl: The effect of adrenaline in peanut oil and adrenaline
pellets on the thyroid gland of the guinea pig and rabbit. Endocrinology !!_:617, 1940.
~

Green, H., Brickson, R. w.: Effect of trans-2-phenylocyclopropylamine
upon norepinephrine concentration and monoamine oxidase attivity in
rat brain. J.P.B.T. ~:237, 1960.
Griesemer , B. c., Barsky, J., Dragsted, c. A., Wells, J. A., and Zeller,
E. A.: Potentiating effect of iproniazid on the pharmacological action of sympathomimetic amines. Proc. Soc. Exptl. Biol. Med. 84:
699, 1953.
Gey, K. F. and Pletscher, A.: Activity of monoamine oxidase in relation
to 5-hydroxytryptamine and norepinephrine content in rat brain. J .
Neurochem. 2_:239, 1961.

Glylys , J. A., Chessin, M., and Warren, M. R.: Effect of phenylethyl
hydrazine and related compounds on response of rabbit aortic strips
and sympathomimetic amines. The Pharmacologist !:82, 1959.
Hawkins, Joyce: The localization of amine oxidase in the liver cell.
Biochem. J. ~:577, 1952.
Hoen, E., Langefeld, H., and Oehme, C.: Relation between thyroid and
adrenal. Endokrinologie _!!:305, 1939.
Horowitz, David and Sjoerdsma, A.: A nonhydrazine monoamine oxidase
inhibitor with antihypertensive properties. (N-benzyl-N-methyl-2propynylamine HCl) Proc • .soc. Exp. Biol. and Med. ~:118, 1961.
Kline, N. s.: Comprehensive therapy of depression.
3_SlS, 1961.
Kohn, H. I.:

Tyramine oxidase.

Biochem. J.

~:1693,

J. Neuropsychiat.

1937.

Kopin, I.: Technique for study of alternate metabolic pathways; epinephrine metabolism in man. Science !.!!_:1372, 1960.
Lang, F. J. and Wense, T.:
Schwerz, med. Wochschr.

Action of adrenaline on the thyroid.
1938.

~:834,

Lardy, H. A. and Maley, G. F.: Metabolic effect of thyroid hormones in
vitro. Recent Progr. Horm. Res. ~:129, 1954.
Lewis, E. B.: Methods of Statistical Analysis.
Boston, Mass., 1953.

Houghton Mifflin

Cc!••

Lipmann, F., and Dutoit, c. R.: Replacement of thyroxin by its nitro
analogue (3,5,3',5' tetranitro thyroni e) Science ~:474, 1951.
Luschinsky, H. L. and Singher, H. o.: Identification and assay of
monoamine oxidase in the human placenta. Arch. Biochem. Biophys.
~:95, 1948.

54.

Martius, c., and Hess, B.:
Biophys . ~:486, 1951.

Mode of action of thyroxin.

Arch. Biochem.

Novick, w. J .: The effect of age and thyroid hormones on the monoamine oxidase of rat heart. Endocrinology ~:SS, 1961.
Oehme, Curt: Adrenal cortex hormone, ascorbic acid, and amino acids
in experimental hyperthyroidism. Arch. exptl. Path. Pharmakol.
_!!!:SS8, 1937.
Oehme, curt: The antithyrotropic action of the adrenal cortex.
Wochschr. ,!!:512, 1936.

Klin.

?letscher, A.: Wirkung von isopropyl-isonicolinsaurehydrazid auf den
stoff wechsel von catecholaminen und S-hydroxytryptamin im gehirn.
Schwerz. med. Wschr. !2,:1532, 1957.
Pugh, c. B. M. and Quastel. J . H.: Oxidation of amines by animal tissue. Biochem. J • .!!:2306 , 1937.
Richter, Otto: Effects of endocrine gland secretions on the adrenaline
production and content of the adrenal glands. Endocrinology ~:305.
1935.
Rokhlina, M. L. and Studitskii, A. N.: The effect of implantation of
the adrenal cortex on the development of thyroid in chick embryos.
Bull. biol. med. exptl . u.s.s.R. ~:171, 1937.
Sawyer, M. B. M. and Brown, M. G.: Effect of thyroidectomy and thyroxine on the response of the denervated heart to adrenaline. Amer.
J. Physiol. 110:620, 1935.
r

Skillen, R. G., Thienes, c. H., and Strain, L.: 5-Hydroxytryptamine,
5-hydroxytryptophan decarboxylase and monoamine oxidase in hearts of
normal , thyroid fed , and propylthronacil fed male and female rats~
Endocrinology ~:743, 1962.
,Snedecor, George
Ames, Iowa.

w.:

Statistical Methods.

Iowa State College Press,

Spector, s., Kuntzman, R., Shore, P. A., and Brodie, B. B.: EVidence
for release of brain amines by reserpine in presence of monoamine
oxidase inhibitors: implication of monoamine oxidase in norepinephrine metabolism in brain. J .P.E. T. 130:256, 1960.
Spector, s., Shore, P. A., and Brodie, B. B.: Biochemic•l and pharmacological effects of the monoamine oxidase inhibitors, iproniazid,
l-phenyl-2-hydrazinopropane (JBS16) and l-phenyl-3-hydrazinobutane
(JB83S). J .P.E. T. ~:15, l960a.
Spinks, A., and Burn, J. H.: Thyroid activity and amine oxidase in
the liver. British J . Pharmacology !• 93, 1952.

SS.

Taylor, J. D. and Krause, R. A.: Distribution and metabolism of the
monoamine oxidase inhibitor (N-methyl-N-benzyl-2-propynylamine hydrochloride) in the rat and dog. Fed. Proc. 3.!_:18lb, 1962.
Taylor , J . D., Wykes, A. A., Gladdish, Y. c. , and Martin, w. B., and
Everett, G. M.: A new nonhydrazine monoamine oxidase inhibitor
(Al9120) (N=rnethyl-N-benzyl-2-propynylamine HCl). Fed. Proc. 19
278c, 1960.
Thibault, o.: Action ren for catrice de la thyroxine sur l'effect in=
hibiteur de l'adrenaline sur l'intestin de lapin isole mise in evidence du phenomene. Compt. rend. soc. biol • .!!3_:499 1 1948.
Tipton, S. R. and Nixon, w. L.: The effect of throuracil on the succi 1~
oxidase and cytochrome oxidase of rat liver. Endocrinology ~:300 ,
1946.
Umbreit, w. w. , Burris, R. H., and Stauffer, J . F.: Manometric Techniques .
Burgess Publishing Co., Minneapolis, Minnesota.
Walasezek, E. and Abood, L. G.: Fixation of 5-hydroxytryptamine by
brain mitochondria. Proc. Soc. Exptl. Bioi. N. Y. , 101:37 1 1959.
Weissbach, H., Louenberg, w., Reefield, B. G., and Udenfriend, s.: In
vivo metabolism of serotonin and tryptamine : effect of monoamine
oxidase inhibition. J.P.E.T. ~:26, 1961•
Westermann, E.: Influence of thyroxine and ttiio:iothyronine on the amine
oxidase and dopa decarboxylase activity of the liver. Arch. Exptl.
Pathol. Pharmakol. 33!!:159, 1956.
Wiegand, R. G. and Perry, J. E.: IX>PA, dopamine, norepinephrine, epinephrine, and serotonin mouse brain levels after N~methyl-N-benzyl2-propynylamine HCl and 1 dopa. Fed. Proc. ~:306c 1 1961.
·
Wiegand, R. G. and Perry, J. E.: ·Effect of 1 dopa and N-methyl-N-benzyl2-propynylamine HCl on dopa, dopamine, norepinephrine, and serotonin
levels in mouse brain. Biochem. Pharm. Z:l8l 1 1961.
Zile, M.: Effect of thyroxine and related compounds on monoamine oxidase activity. Endocrinology ~:311, 1960.
Zile, M. and Lardy, H. A.: Monoamine oxidase activity in liver of
thyroid fed rats. Arch. Biochem. ~:411, 1959.

VIII.

APPENDIX

Constants for total oxygen uptake were calculated by the use of
the formula:
Vg (273) + Vf
k=

T
Po

Vg = volume of gas phase in flask including connecting tubes.

T = temperature of bath in absolute degrees.
Vf

= volume of fluid in vessel.
= solubility in reaction liquid

of gas involved.

Expressed as ml

gas/ml liquid when the gas is at a pressure of 760 mm Hg at the
temperature T.
P0

= standard

pressure.

(Brodie's solution is equivalen to 10,000 mm

Hg.)

The method the least squares was used for regression lines for
· the manometric plots and the regression line relationships were calculated according to Lewis (1953).

zy =Na+
z.xy = ax +

bX
bz.;c2

R0 the null hypothesis stating that the regression line is not

a sample from the universe from which it is drawn.

standard error of the regression

r

t

S
y

r
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